Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,633 | -4,140 | -2,239 | -12,452 | -10,450 |
| Depreciation Amortization | 61 | 41 | 20 | 70 | 48 |
| Income taxes - deferred | N/A | N/A | N/A | -1,621 | -1,621 |
| Accounts payable and accrued liabilities | -20 | 31 | 10 | -608 | -417 |
| Other Working Capital | -319 | 254 | 271 | -530 | -262 |
| Other Operating Activity | 137 | 47 | 31 | 5,627 | 5,389 |
| Operating Cash Flow | $-5,774 | $-3,767 | $-1,907 | $-9,514 | $-7,313 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -203 | -203 |
| Net Acquisitions | N/A | N/A | N/A | 100 | 100 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-103 | $-103 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,433 | 5,501 | 932 | 292 | -74 |
| Financing Cash Flow | $5,433 | $5,501 | $932 | $292 | $-74 |
| Beginning Cash Position | 3,631 | 3,631 | 3,631 | 12,956 | 12,956 |
| End Cash Position | 3,290 | 5,365 | 2,656 | 3,631 | 5,466 |
| Net Cash Flow | $-341 | $1,734 | $-975 | $-9,325 | $-7,490 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,774 | -3,767 | -1,907 | -9,514 | -7,313 |
| Capital Expenditure | N/A | N/A | N/A | -203 | -203 |
| Free Cash Flow | -5,774 | -3,767 | -1,907 | -9,717 | -7,516 |